Background
The global prevalence of end-stage renal disease (ESRD) requiring treatment with dialysis or kidney transplantation continues to increase [
1,
2]. Patients with ESRD experience far greater morbidity, mortality and health care costs than members of the general population, and studies evaluating health outcomes in this high-risk population are required worldwide [
1,
2].
Administrative health care databases offer an efficient and accessible approach to studying outcomes in large populations[
3]. Physician billing claims data are one data source for identifying cases of ESRD because they are routinely collected for physician reimbursement, often span wide geographic areas, and have the potential to capture both in-hospital and outpatient encounters within a healthcare system[
4]. However, before such data sources can be widely adopted for use in research where identification of cases of ESRD is critical, the validity of algorithms used to define case definitions of ESRD requires evaluation.
Limited data demonstrate the validity of administrative data algorithms for identifying patients requiring chronic hemodialysis or peritoneal dialysis. Prior studies have assessed acute kidney injury [
5‐
7], as well as the validity of using
inpatient administrative data to identify chronic dialysis patients [
8‐
13]. The two previous studies considering chronic dialysis in the outpatient setting have considered diagnostic codes [
14,
15], not procedural codes as are considered in this study. This is of particular importance as the majority of contemporary ESRD patients receive chronic dialysis as outpatients. We therefore did this study to determine the validity of algorithms derived from outpatient physician billing claims for defining chronic dialysis, compared to the reference standard of an ESRD registry.
Results
In total 1,118,097 individuals had at least 1 out-patient serum creatinine measure from Jan 1 2008 to Dec 31 2008. During that period 2,227 chronic dialysis patients (0.20% of the total study population) were registered in the ESRD registry. Table
3 presents the baseline characteristics of the overall population, the reference standard dialysis cohort and the cohort resulting from each of the administrative data definitions. The characteristics of the overall cohort are similar to the general Alberta population [
27]. As expected, the dialysis cohort was older (64.0 vs. 52.6 y), had a higher prevalence of diabetes (54.5% vs. 12.7%), hypertension (89.0% vs. 34.7%) and a higher burden of comorbid disease (median number of Charlson comorbidities 3 vs. 0) compared to the total population. As the administrative data definition became more restrictive, the cohort became slightly older with a moderately higher burden of diabetes and hypertension.
Table 3
Baseline cohort characteristics
Mean Age (SD) | 52.6 (17.63) | 64.0 (15.62) | 62.8 (16.2) | 63.2 (16.1) | 63.4 (16.2) | 64.0 (16.0) |
Male (%) | 43.2 | 60.3 | 59.5 | 60.1 | 59.0 | 59.4 |
Diabetes (%) | 12.7 | 54.5 | 51.9 | 52.7 | 53.7 | 54.2 |
Hypertension (%) | 34.7 | 89.0 | 88.5 | 89.5 | 91.9 | 92.1 |
Median number of Charlson Comorbidites (median, IQR*) | 0 (0,1) | 3 (2,5) | 3 (2,5) | 3 (2,5) | 3 (2,5) | 3 (2,5) |
Median number of Outpt Physician Claims in 2008 (median, IQR*) | 8 (4,14) | 67 (24,136) | 80 (35,142) | 90 (42,145) | 124 (69,155) | 129 (81,160) |
The chronic dialysis case definitions based on 1 outpatient claim and 2 outpatient claims resulted in similar prevalence estimates to the reference standard (0.21% and 0.19% respectively). The other two definitions, incorporating claims spanning 90 days, underestimated the prevalence (Table
4). The positive agreement was highest when the definition using 2 outpatient claims was considered. The four coding algorithms for dialysis resulted in sensitivities ranging from 0.58 (Continuous outpatient claims) to 0.81 (at least 1 outpatient claim). The PPVs ranged from 0.77 (at least 1 outpatient claim) to 0.86 (Continuous outpatient claims). The three definitions requiring at least 2 outpatient claims resulted in kappa statistics between 0.60-0.80 indicating "substantial" agreement [
26]. "At least 1 outpatient claim" resulted in "excellent" agreement with a kappa statistic of 0.81, however, given the size of the true negative population this must be interpreted with caution [
24].
Table 4
Validity of physician billing chronic dialysis case definitions compared with reference standard registry case definition
1 outpatient claim | 2324 (0.21%) | 1805 | 519 | 422 | 1,115,351 | 0.793 | 0.811 | 0.777 | 0.793 |
2 outpatient claims | 2171 (0.19%) | 1751 | 420 | 476 | 1,115,450 | 0.796 | 0.786 | 0.807 | 0.796 |
2 outpatient claims at least 90 days apart | 1657 (0.15%) | 1406 | 251 | 821 | 1,115,619 | 0.724 | 0.631 | 0.848 | 0.724 |
Continuous outpatient claims for at least 90 days with no gaps greater than 21 days | 1508 (0.13%) | 1295 | 213 | 932 | 1,115,657 | 0.693 | 0.582 | 0.859 | 0.693 |
Discussion
All four physician claims-based case definitions assessed resulted in "substantial" agreement with our reference standard registry definition for chronic dialysis. One outpatient claim for dialysis was the most sensitive definition, while more complicated definitions exhibited modest increases in positive predictive value. The optimal administrative data definition may vary with the research objective. For example, when seeking to maximize identification of dialysis as an outcome an approach based on at least 1 outpatient claim may be preferable. In contrast, when establishing a cohort of patients with ESRD receiving chronic dialysis that includes the fewest non-diseased cases being captured, the use of continuous outpatient claims may be better suited.
Some of the discrepancies between our registry and physician claims algorithms for chronic dialysis likely relate to differences in the classification of patients who receive temporary dialysis or who die soon after initiating dialysis Traditionally, administrative algorithms and national registries, such as the USRDS, have required a 90-day timeframe to define chronic dialysis [
19,
20]. Although this approach avoids identification of patients who receive temporary dialysis then recover renal function within 3 months, it introduces survivor bias and does not capture chronic dialysis patients that may begin dialysis but die before meeting the inclusion criteria of the definition. Our study demonstrates that approaches based on 1 or 2 outpatient dialysis claims are substantially more sensitive than definitions based on 90 days of claims, although this definition may include some patients who would not be classified as receiving chronic dialysis in a registry (false positive cases). Utilizing a definition that does not require the patient to survive a certain amount of time eliminates any potential survival bias and allows studies of the patient group that begin dialysis and die soon after. However the limitation of this definition is that it may also include patients with acute kidney injury requiring dialysis for a short period who subsequently recover their renal function and no longer require dialysis. Furthermore, estimates of disease incidence and outcomes will not be comparable to studies based on most existing national registries.
Establishing the validity of an outpatient administrative data definition for chronic dialysis will allow researchers to utilize physician billing claims data to assess outcomes and form cohorts. This is of international relevance, even in countries where established dialysis registries are available. In the United States, not all researchers have the means to access the USRDS. In other registries from other countries often only cross-sectional, regional data with limited outcomes are available. Thus, validated methods for identifying chronic dialysis patients using billing claims data would be useful for in health services research.
We found that the use of physician claims data resulted in the classification of patients as receiving dialysis who were not identified as such in our registry (false positives). Most of these patients were removed from the case definition when algorithms which required claims to span 90 days were used. This is in-keeping with the hypothesis that these events may be acute kidney injury cases or patients who were initiated on dialysis but subsequently recovered renal function; i.e., those not considered chronic dialysis patients and thus not captured in the registry. We also found that physician claims failed to identify some patients captured in the registry (false negatives). As Alberta Health and Wellness does not employ any formal quality assurance or correction process, this may be due to missed billings, billing errors, billings made by physicians on alternative payment plans (shadow billing) or miscoding present in administrative data sources, as the number of such patients decreased when algorithms that required less intensive physician claims were employed.
To our knowledge, this is the first study to look at using outpatient administrative data sources using procedure codes to define chronic dialysis. Others have developed algorithms for acute kidney injury and chronic kidney disease using inpatient administrative data [
5‐
13]. Given that the majority of chronic dialysis patients are treated in the outpatient setting, administrative data algorithms limited to inpatient encounters are likely to perform poorly when compared against a reference standard. Three previous studies have included outpatient claim data [
14,
15,
28]. However, Kern et al. excluded chronic dialysis patients, focusing on the validity of administrative data to define chronic kidney disease defined by eGFR <60 ml/min/1.73 m
2 [
28]. Neither Weintraub et al. nor Wilchesky et al. included procedural codes [
14,
15]. Their work was limited to ICD-9-CM diagnosis codes for chronic renal failure. Thus, our study is novel, and could facilitate further health services research in a high risk population with ESRD who experience very high morbidity, mortality, and health care costs.
Our study does have several limitations. First, the billing codes used are from the Canadian Classification of Diagnostic, Therapeutic and Surgical Procedures (CCP); a classification system developed and applied in Canada. However, most countries have similar billing practices and billing codes that could be mapped to the CCP codes. Second, we used a provincial registry of all chronic dialysis patients as the reference standard. Although this registry is geographically inclusive, some dialysis patients may be omitted from the registry in error, thereby resulting in misclassification. However, as this registry is linked to ongoing dialysis treatment, the number of patients not registered is expected to be small. Third, our study did not distinguish between dialysis modalities (hemodialysis versus peritoneal dialysis, or in-centre versus home dialysis), and the accuracy of patient registry and physician claims in these settings may vary. However, prior research has reported limitations in the accuracy of administrative data for identifying the timing of changes between dialysis modalities suggesting that administrative data sources may be better suited to the general identification of patients receiving chronic dialysis rather than a specific modality [
29].
Conclusions
We found that outpatient physician claims identified patients receiving chronic dialysis with "substantial" agreement to a reference standard dialysis registry definition. The use of 1 or 2 outpatient claims was most sensitive; however, had modestly lower positive predictive value than claims spanning 90 days or continuous claims. Given the variation in the way clinicians, researchers, and research tools define chronic dialysis, the optimal physician claims based definition will vary with the research objective.
Acknowledgements
Drs. Tonelli, Hemmelgarn, and Manns were supported by New Investigator awards from the Canadian Institutes of Health Research. Dr James was supported by a KRESCENT (Kidney Foundation of Canada) and Alberta Heritage Foundation for Medical Research (AHFMR) Fellowship. Drs. Tonelli and Manns are supported by Alberta Innovates - Health Solutions Health Scholar Awards. Drs Klarenbach, and Hemmelgarn were supported by Population Health Investigator awards from Alberta Innovates - Health Solutions, and Dr. Klarenbach was supported by a Scholarship Award from the Kidney Foundation of Canada. Drs. Tonelli, Klarenbach, Hemmelgarn, Quinn, James and Manns were supported by an alternative funding plan from the Government of Alberta and the Universities of Alberta and Calgary.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
All the authors contributed to the conception and design. FC, MJ, RC and BR contributed to the data analysis and drafted the report. All of the authors contributed to the interpretation of data, critically revised the manuscript for important intellectual content and approved the final version submitted for publication.